Results of Round 3 National Blood Sector Research and Development Program

Applications to Round 3 of the National Blood Sector Research and Development Program closed on 1 June 2018. The NBA thanks all applicants who submitted an application to this round and is grateful to have received high quality input from clinical, research and government experts who participated in the review process and assisted the NBA in determining the mix of projects to be funded within the limited program budget.  The NBA is confident that the research funded through this round will provide significant contributions to the development of new knowledge in the blood sector. Congratulations to the grant awardees. Successful applications are listed below:

Patient Blood Management Project Grants

Principal Chief Investigator

Administering Institution

Amount (incl. GST)

Project Title

Prof Helen Liley

University of Sydney

$161,151.10

Deferred Cord Clamping to Reduce Need for Neonatal Blood Transfusion

Dr James Winearls University of Queensland $491,345.80 Fibrinogen Replacement in Severe Traumatic Haemorrhage (FEISTY II)

Immunoglobulin Project Grants

Principal Chief Investigator

Administering Institution

Amount (incl. GST)

Project Title

Dr Zoe McQuilten

Monash University

$494,220.10

Immunoglobulin use in Chronic lymphocytic leukaemia And Non-Hodgkin lymphoma – the ICAN study

Patient Blood Management Seed Grants

Principal Chief Investigator

Administering Institution

Amount (incl. GST)

Project Title

Dr Amanda Henry

University of New South Wales

$50,737.50

Concealing treatment in pregnancy anaemia randomised trials: can it be used?

Dr Philip Crispin Australian National University $73,799.00 Transfusion Strategies for Low Platelets